David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Stanford wants Secukinumab trialists

Written by on August 5, 2017 in clinical trials, research with 0 Comments

A clinical trial at Stanford Dermatology is seeking trialists to join a study looking at Secukinumab as a treatment for the papules and pustules, and redness associated with rosacea. If you are interested, and meet the requirements for the trial, please contact them via their details below. What is Secukinumab? Secukinumab (brand name Cosentyx) has recently become […]

Continue Reading

Rhofade scores a mention in The New York Times

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy. How to Go Makeup-Free This Summer By CRYSTAL MARTIN AUG. 1, […]

Continue Reading

Soolantra worth $87m in the last year

Written by on July 18, 2017 in patents, Soolantra (Ivermectin Cream 1%) with 0 Comments
Soolantra worth $87m in the last year

One thing we have learned from the news that Perrigo and Galderma are embarking on a patent dispute, is how successful Soolantra has been as a product. Perrigo Confirms Patent Challenge For Generic Version Of Soolantra Cream, 1% Soolantra (ivermectin) cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Annual market sales […]

Continue Reading

Rosacea means drier, redder and sweaty skin

Written by on July 8, 2017 in blushing, flushing with 1 Comment
Rosacea means drier, redder and sweaty skin

This paper is full of technical terms, but contains some simply stated outcome for rosacea suffers. Researchers can see that rosacea sufferers have more water loss from the surface of their skin (i.e. their skin gets drier and potentially more irritated) , greater dilation of blood vessels and more rapid sweating than the general population. […]

Continue Reading

Soolantra is both anti-inflammatory and anti-demodex

Soolantra is both anti-inflammatory and anti-demodex

This paper is exploring the reasons for Soolantra’s success in treating the lumps and bumps of rosacea; its dual method of action – both as an antiparasitic and anti-inflammatory. The research was able to show that along with the improvement in rosacea symptoms, trialists had a significant reduction in the amount of demodex mites present […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.